Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04340388 · ClinicalTrials.gov registry record · Phase 4
Contribution of Dolutegravir to Obesity and Cardiovascular Disease
A Phase 4 study, sponsored by Augusta University.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT04340388: Completed Phase 4 study, sponsored by Augusta University.
NCT04340388 is a Phase 4 study that has completed, run by Augusta University. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04340388, a Phase 4 study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of the study is to combine a collaborative and translational approach to evaluate the effect antiretroviral regimen switch to a dolutegravir containing regimen compared to continued treatment with a non- dolutegravir based regimen on on lipid and metabolic profiles, renal function, body composition, vascular function and diet.
Primary Outcome
Change from baseline kilograms (kg) of weight at 24 weeks
Interventions
- DRUG Dolutegravir 50 MG
- DRUG Antiretroviral/Anti HIV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-09-17 |
| Est. Completion | 2023-02-25 |
| Phase | Phase 4 |
What the finished NCT04340388 record still lists
NCT04340388 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Dolutegravir 50 MG is the first listed.
NCT04340388 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04340388 about?
NCT04340388 is a clinical study titled "Contribution of Dolutegravir to Obesity and Cardiovascular Disease". The goal of the study is to combine a collaborative and translational approach to evaluate the effect antiretroviral regimen switch to a dolutegravir containing regimen compared to continued treatment with a non- dolutegravir based regimen on on lipid and metabolic profiles, renal function, body com...
What is the current status of trial NCT04340388?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2020-09-17. Estimated completion is 2023-02-25.
What interventions are being tested in trial NCT04340388?
The interventions under investigation include: Dolutegravir 50 MG (DRUG), Antiretroviral/Anti HIV (DRUG).
Who is sponsoring clinical trial NCT04340388?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04340388's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI